Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 601–700 of 1,000
Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
Wang, Z., Zhao, Y., An, Z., & Li, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01491 · Cited by 27
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Gelosa, P., Castiglioni, L., Camera, M., & Sironi, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113895 · Cited by 28
Gomez-Nguyen, A., Gupta, N., Sanaka, H., Gruszka, D., Pizarro, A., DiMartino, L., Basson, A. R., Menghini, P., Ösme, A., Salvo, C. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208160119 · Cited by 26
“12-wk–old SAMP mice for 56 consecutive days (23, 24).”
BackgroundAshworth, A., Balkwill, F. R., Bast, R. C., Berek, J. S., Kaye, A., Boyd, J. A., Mills, G. B., Weinstein, J. N., Woolley, K., & Workman, P. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.11.014 · Cited by 26
The Association of Work Characteristics With Ovarian Cancer Risk and Mortality
Trudel‐Fitzgerald, C., Poole, E. M., Idahl, A., Lundin, E., Sood, A. K., Kawachi, I. I., Kubzansky, L. D., & Tworoger, S. S. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000464 · Cited by 28
“Up-regulation of catecholamines, specifically norepinephrine and activation of -adrenergic pathways (7-10), is a primary mechanism of the stress-OvCA linkage.”
BackgroundSelf-citationLutgendorf, S. K., Penedo, F. J., Goodheart, M. J., Dahmoush, L., Arevalo, J. M. G., Thaker, P. H., Slavich, G. M., Sood, A. K., & Cole, S. W. (2020) · Cancer · doi:10.1002/cncr.33060 · Cited by 28
Self-citationProtein Kinase A-regulated Nucleocytoplasmic Shuttling of Id1 during Angiogenesis
Nishiyama, K., Takaji, K., Uchijima, Y., Kurihara, Y., Asano, T., Yoshimura, M., Ogawa, H., & Kurihara, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611609200 · Cited by 26
Tumor interactions with soluble factors and the nervous system
Voss, M. J., & Entschladen, F. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-21 · Cited by 25
“Chronic stress has been implicated in tumor progression as early as 1926 [17], and several lines of epidemiological [18,19] and animal studies [20,21] support this view.”
Resultβ-Blockers Promote Angiogenesis in the Mouse Aortic Ring Assay
Stati, T., Musumeci, M., Maccari, S., Massimi, A., Corritore, E., Strimpakos, G., Pelosi, E., Catalano, L., & Marano, G. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000085 · Cited by 25
Lee, D., Shin, Y., Jang, J., Park, Y.-H., Ahn, J., Jeong, S., Shin, S. S., & Yoon, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112646 · Cited by 27
Sakakitani, S., Podyma‐Inoue, K. A., Takayama, R., Takahashi, K., Ishigami‐Yuasa, M., Kagechika, H., Harada, H., & Watabe, T. (2020) · Cancer Science · doi:10.1111/cas.14670 · Cited by 25
Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation
Ishikawa, M., Iwasaki, M., Sakamoto, A., & Ma, D. (2021) · BMC Anesthesiology · doi:10.1186/s12871-021-01294-w · Cited by 27
Aquino-Acevedo, A. N., Knochenhauer, H. E., Castillo-Ocampo, Y., Ortiz-León, M., Rivera-López, Y. A., Morales-López, C., Cruz-Robles, M. E., Hernández-Cordero, E. R., Russell, S., Whitaker, R. S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100558 · Cited by 28
Lee, J.-Y., Park, H. Y., Jung, D., Moon, M.-H., Keam, B., & Hahm, B. (2014) · Psycho-Oncology · doi:10.1002/pon.3503 · Cited by 25
“We also provided excerpts from medical literature: possible association between chronic stress and cancer progression [32] and the effectiveness of pharmacotherapy in cancer patients [33].”
Anesthesia and cancer recurrence
Divatia, J. V., & Ambulkar, R. P. (2014) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.129990 · Cited by 25
Yamazaki, S., Sakakibara, H., Takemura, H., Yasuda, M. T., & Shimoi, K. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.014 · Cited by 25
Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention
Chang, A., Kim-Fuchs, C., Le, C. P., Hollande, F., & Sloan, E. K. (2015) · Cancers · doi:10.3390/cancers7030838 · Cited by 25
“stress neurotransmitters and hormones [73,74,78].”
BackgroundResultInfluentialAutonomic regulation of hematopoiesis and cancer
Toro, R. D., & Méndez‐Ferrer, S. (2013) · Haematologica · doi:10.3324/haematol.2013.084764 · Cited by 30
“Stress-induced release of catecholamines has been shown to activate the β2-adrenergic receptor on ovarian carcinoma cells and trigger increased expression of vascular endothelial growth factor (VEGF), resulting in enhanced tumor vascularization and more aggressive growth and spread of malignant cells.(32) Similarly,”
BackgroundImpact of Cardiovascular Comorbidity on Ovarian Cancer Mortality
Shinn, E. H., Lenihan, D. J., Urbauer, D. L., Basen‐Engquist, K., Valentine, A. D., Palmero, L. C., Woods, M. L., Patel, P., Nick, A. M., Shahzad, M. M. K., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0625 · Cited by 29
Self-citationSerum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma
Abdel‐Hamid, N. M., Shehata, D. E., Abdel-ghany, A. A., Ragaa, A., & Wahid, A. M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.005 · Cited by 26
Ashrafi, S., Shapouri, R., & Mahdavi, M. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.11.014 · Cited by 26
Colón-Echevarria, C. B., Ortíz, T., Maldonado, L., Hidalgo-Vargas, M. J., Pérez‐Morales, J., Aquino-Acevedo, A. N., Herrera-Noriega, R., Bonilla-Claudio, M., Castro, E., & Armaiz-Peña, G. N. (2020) · Cancers · doi:10.3390/cancers12092671 · Cited by 25
“The derivation and source of the established SKOV3, SKOV3ip1, and HeyT30 ovarian cancer cell lines have been reported previously [3,40,41].”
BackgroundMethodInfluentialThe mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells
Yuan (2009) · Oncology Reports · doi:10.3892/or_00000616 · Cited by 26
Shao, W., Wang, B., Wang, P., Zhang, S., Gong, S., Guo, X., Duan, D., Shao, Z., Liu, W., He, L., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00371-3 · Cited by 25
Transcriptom analysis revealed regulation of dexamethasone induced microRNAs in chicken thymus
Zhou, Y., Tian, W., Zhang, M., Ren, T., Sun, G., Jiang, R., Han, R., Kang, X., & Yan, F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27950 · Cited by 24
“The previous research reported that the animals under the long‐term stress, the transplant tumors were more easy to grow, rapid development, and high mortality.(31) miR‐148a‐3p was expressed and may be involved in some regulation of organ development in chicken.”
Spotlight on ROS and β 3-Adrenoreceptors Fighting in Cancer Cells
Calvani, M., Subbiani, A., Vignoli, M., & Favre, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6346529 · Cited by 28
“β1- and β2-ARs are expressed higher in non-small-cell lung cancer [159, 160], pancreatic cancer [161, 162], breast cancer [163, 164], ovarian carcinoma [165, 166], colorectal carcinoma [167], prostate cancer [168], and melanoma [169], while β3-ARs are detected in colon and breast cancer [155, 170], vascular tumors [17…”
BackgroundSivanesan, S., Taskén, K. A., & Grytli, H. H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.45230 · Cited by 25
Abdin, A. A., Soliman, N. A., & Saied, E. M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.07.010 · Cited by 29
Lowery, W. J., Stany, M. P., Phippen, N. T., Bunch, K. P., Oliver, K., Tian, C., Maxwell, G. L., Darcy, K. M., & Hamilton, C. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.027 · Cited by 25
“VEGF expression in tumor specimens taken from chronically stressedmicewas significantly higher compared to control mice further correlating psychosocial conditions with tumor biology [16].”
BackgroundKim, S. H., Cho, K. H., Kim, Y. N., Jeong, B. Y., Park, C. G., Hur, G. M., & Lee, H. Y. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0666-8 · Cited by 27
Neural regulation of cancer: from mechanobiology to inflammation
Kim, T. P., Rowat, A. C., & Sloan, E. K. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.18 · Cited by 27
Self-citationProteomic Analysis of Liver Proteins in a Rat Model of Chronic Restraint Stress-Induced Depression
Li, C., Guo, Z., Zhao, R., Sun, W., & Xie, M. (2017) · BioMed Research International · doi:10.1155/2017/7508316 · Cited by 25
Dawes, R. P., Burke, K. A., Byun, D. K., Xu, Z., Stastka, P., Chan, L., Brown, E. B., & Madden, K. S. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420931511 · Cited by 28
A chronic combinatory stress model that activates the HPA axis and avoids habituation in BALB/C mice
Zamora-González, E. O., Santerre, A., Palomera‐Ávalos, V., & Morales‐Villagrán, A. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.10.015 · Cited by 30
Muthig, V., Gilsbach, R., Haubold, M., Philipp, M., Ivacevic, T., Gessler, M., & Hein, L. (2007) · Circulation Research · doi:10.1161/circresaha.107.151563 · Cited by 31
Depression and Risk of Cancer Progression: An Elusive Link
Irwin, M. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7292 · Cited by 24
“Depression is well known to be associated with increases of sympathetic catecholamines,(15) and recent data suggest that such stress mediators modulate tumor growth by inducing the release of angiogenic cytokines and promoting angiogenesis and tumor growth.(16) Of further relevance to hepatobiliary carcinoma, in which…”
BackgroundJin, M., Wang, Y., Zhou, T., Li, W., & Wen, Q. (2023) · Journal of Breast Cancer · doi:10.4048/jbc.2023.26.e25 · Cited by 28
“NE levels in serum and tumor tissues were abnormally elevated under the chronic confinement stress which promoted tumor growth [35-37].”
BackgroundNovel approaches to clinical trial design in cancer neuroscience
Jones, G., Anderson, J. L., Nguyen, P. T., Gleber‐Netto, F. O., Hwang, W. L., Puduvalli, V. K., Monje, M., & Amit, M. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.015 · Cited by 27
The induction of thioredoxin-1 by epinephrine withdraws stress via interaction with β-arrestin-1
Jia, J., Zeng, X., Zhou, X., Li, Y., & Bai, J. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949214 · Cited by 23
Self-citationA prospective study of phobic anxiety, risk of ovarian cancer, and survival among patients
Poole, E. M., Kubzansky, L. D., Sood, A. K., Okereke, O. I., & Tworoger, S. S. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0739-0 · Cited by 26
“Mouse models suggest that chronic distress leads to larger and more aggressive ovarian tumors [4]; in ovarian cancer patients, chronic distress has been associated with higher levels of circulating markers of inflammation, angiogenesis, and immune activation [5–9].”
Self-citationOuyang, X., Zhu, Z., Yang, C., Wang, L., Ding, G., & Jiang, F. (2019) · Europe PMC (PubMed Central) · Cited by 30
Autonomic nervous system control of multiple myeloma
Cheng, Y., Sun, F., D’Souza, A., Dhakal, B., Pisano, M. D., Chhabra, S., Stolley, M. R., Hari, P., & Janz, S. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100741 · Cited by 26
Wang, X., Zhang, L., Zhou, Y., Wang, Y., Wang, X., Zhang, Y., Quan, A., Mao, Y., Zhang, Y., Qi, J., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0378 · Cited by 25
Cancer neuroscience of brain metastasis: When in Rome, do as the Romans do
Karreman, M. A., & Winkler, F. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.003 · Cited by 25
Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone
Elefteriou, F. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.003 · Cited by 26
Zinnah, K. M. A., & Park, S. (2019) · Anticancer Research · doi:10.21873/anticanres.13877 · Cited by 26
The biology and engineered modeling strategies of cancer-nerve crosstalk
Gregory, E., Dugan, R., David, G., & Song, Y. H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188406 · Cited by 23
Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer
Liang, Y., Li, H., Gan, Y., & Tu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.688953 · Cited by 24
“The activation of β-AR can promote tumor growth and angiogenesis via VEGF and metalloproteinase MMP2/MMP9 signaling pathways (Thaker et al., 2006).”
BackgroundLu, Y., Zhang, Y., Zhao, H., Li, Q., Liu, Y., Zuo, Y., Xu, Q., Zuo, H., Li, Y., & Li, Y. (2021) · Journal of Cancer · doi:10.7150/jca.65403 · Cited by 26
“The two pathways have common target adrenergic receptors, which leads to poor prognosis and increased mortality in cancer patients [6; 7].”
BackgroundSelf-citationUltrasensitive quantification of trace amines based on N-phosphorylation labeling chip 2D LC-QQQ/MS
Bian, X., Zhang, Y., Li, N., Shi, M., Chen, X., Zhang, H., Liu, J., & Wu, J. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.02.003 · Cited by 22
Abdullahi, A., Wong, T. W. L., & Ng, S. S. M. (2023) · Cancer Medicine · doi:10.1002/cam4.6466 · Cited by 25
Cho, S., Sun, Y., Soisson, A. P., Dodson, M. K., Peterson, C. M., Jarboe, E. A., Kennedy, A., & Janat-Amsbury, M. M. (2013) · PubMed · Cited by 27
The major stressful life events and cancer: stress history and cancer
Taş, F., Karalar, U., Aliustaoğlu, M., Keskın, S., Can, G., & Cinar, F. E. (2011) · Medical Oncology · doi:10.1007/s12032-011-9927-7 · Cited by 22
“[8] found that chronic behavioral stress results in higher levels of tissue catecholamines as a sympathetic nervous system activity might mediate a causal effect of stress on the growth and metastasis of ovarian cancer cells in an orthotopic mouse model.”
BackgroundRole for catecholamines in tumor progression
Yang, E. V. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.12260 · Cited by 22
Xie, W., Xie, H., Liu, F., Li, W., Dan, J., Mei, Y., Dan, L., Xiao, X., Li, J., & Chen, X. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12193 · Cited by 22
Association between depressive disorders and risk of breast cancer recurrence after curative surgery
Chen, S.-J., Chang, C.-H., Chen, K.-C., & Liu, C. (2016) · Medicine · doi:10.1097/md.0000000000004547 · Cited by 27
“Apart from this, strong evidence shows that cortisol dysregulation is common in depression.([17,29]) The HPA axis dysregulation associated with depression may worse the cortisol dysregulation and result in shorter survival.”
BackgroundLeschak, C. J., Dutcher, J. M., Haltom, K. E. B., Breen, E. C., Bower, J. E., & Eisenberger, N. I. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsz103 · Cited by 25
“models of cancer (Palermo-Neto, de Oliveira Massoco, & Robespierre de Souza, 2003; Thaker et al., 2006), including breast cancer (Campbell et al.”
Ogawa, H., Kaira, K., Motegi, Y., Yokobori, T., Takada, T., Kato, R., Osone, K., Takahashi, R., Suga, K., Ozawa, N., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01645-6 · Cited by 22
Self-citationThe Autonomic Regulation of Tumor Growth and the Missing Links
Bautista, M., & Krishnan, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00744 · Cited by 22
“showed that activation of Adrβ2 by NE induces VEGF in ovarian cancer cells (9).”
BackgroundInfluentialZinnah, K. M. A., & Park, S. (2021) · Oncology Reports · doi:10.3892/or.2021.8095 · Cited by 23
“Animal model studies have shown that behav‐ ioral stress induces the rapid development of prostate (20), ovarian (21), pancreatic (22), and breast cancer (22), as well Sensitizing TRAIL‐resistant A549 lung cancer cells and enhancing TRAIL‐induced apoptosis with the antidepressant amitriptyline”
BackgroundShaashua, L., Sominsky, L., Levi, B., Sorski, L., Reznick, M., Page, G. G., & Ben‐Eliyahu, S. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.012 · Cited by 28
Effects of Cigarette Smoking and Restraint Stress on Human Colon Tumor Growth in Mice
Wong, H. P. S., Li, Z. J., Shin, V. Y., Tai, E. K. K., Wu, W. K. K., Yu, L., & Cho, C. H. (2009) · Digestion · doi:10.1159/000231898 · Cited by 22
“In a mouse model of ovarian carcinoma, restraint stress has been shown to increase tumor burden and enhance angiogenesis [”
BackgroundKaira, K., Kamiyoshihara, M., Kawashima, O., Endoh, H., Imaizumi, K., Sugano, M., Tanaka, S., Fujita, A., Kogure, Y., Shimizu, A., et al. (2018) · Anticancer Research · doi:10.21873/anticanres.13125 · Cited by 22
Rentscher, K. E., Carroll, J. E., Polsky, L. R., & Lamkin, D. M. (2022) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2022.100461 · Cited by 21
Hanley, G. E., Kaur, P., Berchuck, A., Chase, A., Grout, B., Deurloo, C. M., Pike, M. C., Richardson, J. L., Terry, K. L., Webb, P. M., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.05.021 · Cited by 21
Antihypertensive medication use and ovarian cancer survival
Huang, T., Townsend, M. K., Dood, R. L., Sood, A. K., & Tworoger, S. S. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.09.009 · Cited by 21
Self-citationShao, F., Liu, Z., Wei, Q., Yu, D., Zhao, M., Zhang, X., Gao, X., Fan, Z., & Wang, S. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230133 · Cited by 22
“It was reported that stress can activate the cAMP – protein kinase A signaling pathway (Thaker et al., 2006).”
BackgroundResultZhang, J., Deng, Y., Liu, J., Gan, L., & Jiang, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2366451 · Cited by 24
“14,37 41 We have reported that chronic stress-induced colorectal adenocarcinoma HT-29 cell EMT stimulated HT-29 cell migration and invasion, and weakened the anti-tumor effect of sunitinib in vivo .”
BackgroundMethodEnriched environment inhibits breast cancer progression in obese models with intact leptin signaling
Foglesong, G. D., Queen, N. J., Huang, W., Widstrom, K. J., & Cao, L. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0075 · Cited by 23
Liu, D., Zha, L., Liu, Y., Zhao, X., Xu, X., Liu, S., Ma, W., Zheng, J., & Shi, M. (2020) · Cancer Science · doi:10.1111/cas.14676 · Cited by 23
Zhang, H., Chen, M., Liu, Y., Dong, X., Zhang, C., Jiang, H., & Chen, X. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9370 · Cited by 21
“In patients with malignant tumors, depression affects immune function, thus altering the occurrence, development and outcomes of malignant tumors (12,27,28).”
BackgroundMechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis
Madel, M., & Elefteriou, F. (2021) · Cancers · doi:10.3390/cancers13122887 · Cited by 26
“However, in vivo preclinical studies have demonstrated that stimulation of the SNS favors tumor metastasis in the absence of NK and cytotoxic T cells [53,110,132,140,141], thus suggesting the existence of T- and NK-cell-independent mechanisms contributing to the engraftment of metastatic tumor cells into the skeleton.”
BackgroundPrinsloo, S., Wei, Q., SCOTT, S. M., Tannir, N. M., Jonasch, E. W., Pisters, L. L., & Cohen, L. G. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-014-9578-1 · Cited by 21
“The majority of research in health psychology has focused on patients’ negative psychological states or traits after diagnosis of diseases, including cancer (Reiche et al. 2005; Thaker et al. 2006) however positive psychological states”
The Role of β-Blockers in Melanoma
GIORGI, V. D., Geppetti, P., Lupi, C., & Benemei, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09876-9 · Cited by 21
Lü, J., Zhang, X., Su, K., Luo, H., Liu, C., Yang, Y., He, B., Wang, C., Zhao, Z., Liu, X., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01747-y · Cited by 22
Li, W., Zhang, J., Gao, Y., Kong, X., & Sun, X. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189345 · Cited by 25
Vrotsos, E., Rego, C., Cusnir, M., Tuda, C. D., & Sriganeshan, V. (2014) · journal of cancer therapeutics and research · doi:10.7243/2049-7962-3-6 · Cited by 20
“Noraepinefrine (NE) has been shown to up-regulate VEGF in adipose tissue through the ADRB–cAMP–PKA pathway [49] Similar findings have been noted in ovarian cancer cell lines and these effects were abolished by a β-blocker, propranolol, and mimicked by isoproterenol [43].”
BackgroundZubeldia-Plazaola, A., Recalde‐Percaz, L., Moragas, N., Alcaraz, M., Chen, X., Mancino, M., Fernández‐Nogueira, P., de Puig, M. P., Guzmán, F., Noguera‐Castells, A., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0977-z · Cited by 20
The Role of Neural Signaling in the Pancreatic Cancer Microenvironment
Takahashi, R., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14174269 · Cited by 23
“Recent studies have demonstrated the important roles of autonomic nerves such as sympathetic and parasympathetic nerves in the tumorigenesis of prostate cancer [12,13], ovarian cancer [14], gastric cancer [15,16], and basal cell carcinoma [17].”
BackgroundSelf-citationBu, C., Hu, S., Yu, J., Li, N., Gu, J., Sheng, Z., Yan, Z., & Bu, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03032-1 · Cited by 21
“In addition, it was reported that chronic stress accelerated pancreatic cancer and ovarian carcinoma progression [21, 22].”
BackgroundZidan, A., Saadany, A. A. E., Maghraby, G. M. E., Abdin, A. A., & Hedya, S. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116448 · Cited by 20
Baghaie, L., Haxho, F., Leroy, F., Lewis, B., Wawer, A., Minhas, S., Harless, W. W., & Szewczuk, M. R. (2023) · Cells · doi:10.3390/cells12232767 · Cited by 22
Battistoni, A., Mastromarino, V., & Volpe, M. (2015) · Clinical Cardiology · doi:10.1002/clc.22394 · Cited by 22
Yang, E. V., & Eubank, T. D. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130325 · Cited by 24
Miyato, H., Kitayama, J., Ishigami, H., Kaisaki, S., & Nagawa, H. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1562-1 · Cited by 20
Kalliomäki, T., McCallum, G. P., Lunt, S. J., Wells, P. G., & Hill, R. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-151 · Cited by 20
“This is likely due to various extra stressors in the gassed mice such as handling, temporary (4 hr) absence of food and water and exposure to foreign cage mates, conditions that have all been reported to have the potential to modify tumour progression [44-46].”
BackgroundAre Beta Blockers New Potential Anticancer Agents?
Akbar, S., & Alsharidah, M. S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9567 · Cited by 20
Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study
Couttenier, A., Lacroix, O., Silversmit, G., Vaes, E., Schutter, H. D., & Robert, A. R. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101579 · Cited by 22
Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells
Li, Y., Yang, S., Sadaoui, N. C., Hu, W. M., Dasari, S. K., Mangala, L. S., Sun, Y., Zhao, S., Wang, L., Liu, Y., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101289 · Cited by 24
Self-citationRenna, M. E., Shrout, M. R., Madison, A. A., Alfano, C. M., Povoski, S. P., Lipari, A. M., Agnese, D. M., Carson, W. E., & Kiecolt‐Glaser, J. K. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104866 · Cited by 24
Subclinical cardiac damage in cancer patients before chemotherapy
Fabiani, I., Panichella, G., Aimo, A., Grigoratos, C., Vergaro, G., Pugliese, N. R., Taddei, S., Cardinale, D. M., Passino, C., Emdin, M., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10151-4 · Cited by 22
Effects of Complementary and Integrative Medicine on Cancer Survivorship
Frenkel, M. A., Sierpina, V. S., & Sapire, K. J. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0445-1 · Cited by 24
Li (2009) · Oncology Reports · doi:10.3892/or_00000575 · Cited by 20
“The effects of psychological stress on cancer cells are mediated by the key stress hormones and their corresponding receptors (8,9).”
Chronic Restraint Stress in Oral Squamous Cell Carcinoma
Rivera, C., Droguett, D., Kemmerling, U., & Venegas, B. (2011) · Journal of Dental Research · doi:10.1177/0022034511399911 · Cited by 27
“Available results in mice show that exposure to stress causes specific effects directly on the host immune system and concomitantly influences tumor growth and cancer cell functions (Saul et al., 2005; Antoni et al., 2006; Thaker et al., 2006).”
BackgroundInfluentialBirmann, B. M., Barnard, M. E., Bertrand, K. A., Bao, Y., Crous‐Bou, M., Wolpin, B. M., Vivo, I. D., & Tworoger, S. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303337 · Cited by 22
Central regulation of breast cancer growth and metastasis
Borniger, J. C. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.107 · Cited by 23
“Thaker, Sood & colleagues provided empirical evidence that psychological stress can facilitate tumor growth in multiple animal models via its promotion of glucocorticoid and adrenergic signaling[12,93].”
BackgroundPsychological stress on cancer progression and immunosenescence
Huang, Y., Zhan, Y., & Zhan, Y. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.007 · Cited by 20
Hou, T., Ding, H., Huang, G., Meng, T., & Song, D. (2026) · Cellular Oncology · doi:10.1007/s13402-025-01151-9 · Cited by 21
“Norepinephrine, released by sympathetic nerves, binds β-adrenergic receptors to activate cAMP/PKA and MAPK signaling, driving proliferation, epithelial-mesenchymal transition, and immune evasion in breast, prostate, and ovarian cancers [ 3, 4].”
Li, W., Zhou, R., Zheng, J., Sun, B., Jin, X., Hong, M. H., & Chen, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011450 · Cited by 23
Effects of surgical trauma and intraoperative blood loss on tumour progression
Jin, X., Han, H., & Liang, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1412367 · Cited by 20
“These mechanisms are essential for metastatic spread and growth of tumour cells, and therefore, blocking them may inhibit metastasis (48 – 50).”
Background
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.